synthesized. These ligands and ruthenium compounds were all characterized by 1H and 13C NMR spectroscopy and some of their structures are also determined by single crystal X-ray crystallography. The Ru-1∼Ru-9 showed excellent GI50 for PC-3 and DU-145 with the range of 3.83–12.13 and 4.25–11.22 μM, respectively. Among of these ruthenium compounds, Ru-6 has the best activity indicating phenyl ring is the key
一系列双齿
吡咯亚胺配体[C 4 H 3 NH-(2-CH = NR)](1,R =
环己烯基; 2,R = CH 2 CH 2 -1-
环己烯基; 3,R = t Bu ;4,R = CH 2 -2-
呋喃基;5,R = 2-
甲氧基苯基;6,R =苯基;7,R = 3-
硝基苯基;8,R = 2,6-
二异丙基苯基;9,R = 1。 2,4,6-三甲基苯基),合成和它们相应的
钌金属化合物茹(ɳ 6 -p -cymene)[C 4 H ^ 3N-(2-CH = NR)]
氯}(Ru的1〜孺-9 )还合成。这些
配体和
钌化合物均通过1 H和13 C NMR光谱表征,并且其某些结构也通过单晶X射线晶体学确定。的Ru的1〜茹-9显示出优异的胃肠道50的PC-3和DU-145与3.83-12.13和4.25-11.22μM的范围内,分别。在这些
钌化合物中,Ru-6具有最佳活性,表明苯环是这些
钌化合物
亚胺取代基上的关键基团。